Stay updated on Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial

Sign up to get notified when there's something new on the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.3.2 has been added and the previous v3.3.1 revision has been removed.
    Difference
    0.0%
    Check dated 2025-12-01T16:49:49.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a note that publications are automatically pulled from PubMed and may not relate to the study, and updated the revision to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T13:43:52.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The notice about a lapse in government funding was removed from the page. This is a non-significant change to page messaging; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:34:52.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    No meaningful changes detected in the Study Details page between the two screenshots; core information remains the same.
    Difference
    0.3%
    Check dated 2025-11-03T01:11:31.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    3%
    Check dated 2025-10-05T09:52:03.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new version is available.
    Difference
    0.1%
    Check dated 2025-09-28T03:11:25.000Z thumbnail image

Stay in the know with updates to Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page.